Menu

Experience

Bill Morrow

    • HTG Completes its Initial Public Offering 


    • KemPharm Completes its IPO 


    • Cooley Advises Xencor on its Initial Public Offering 


    • New Relic Completes $132 Million Initial Public Offering 


    • New Relic Completes $132 Million Initial Public Offering  


    • AOL Acquisition of Vidible 


    • Atara – $63 Million IPO and Follow-On Offerings 


    • MobileIron $100 Million Initial Public Offering 


    • Norwest Venture Partners on Formation of $1.2 Billion Fund 


    • Aerohive Networks $75 Million IPO 


    • Auspex $96 Million Initial Public Offering 


    • Cooley Advises Auspex on its Initial Public Offering 


    • Jazz Pharmaceuticals $125 Million Acquisition of ADX-N05 


    • Xencor Initial Public Offering 


    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 


    • Backflip Studios $112 Million Acquisition by Hasbro 


    • Portola Pharmaceuticals $140 Million IPO 


    • Ambit Initial Public Offering 


    • Receptos, Inc. Initial Public Offering 


    • Cooley Advises Ambit on its IPO 


    • Hot Topic $600 Million Sale to Sycamore Partners 


Contact us

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.